Month: November 2020

');$vidEndSlate.removeClass('video__end-slate--inactive').addClass('video__end-slate--active');}};CNN.autoPlayVideoExist = (CNN.autoPlayVideoExist === true) ? true : false;var configObj = {thumb: 'none',video: 'health/2020/09/30/faf-heart-health-diet-howard.cnn',width: '100%',height: '100%',section: 'domestic',profile: 'expansion',network: 'cnn',markupId: 'large-media_0',adsection: 'const-article-pagetop',frameWidth: '100%',frameHeight: '100%',posterImageOverride: {"mini":{"width":220,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200930145454-faf-heart-health-diet-howard-00004421-small-169.jpg","height":124},"xsmall":{"width":307,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200930145454-faf-heart-health-diet-howard-00004421-medium-plus-169.jpg","height":173},"small":{"widt...

Researchers studying coronavirus patients’ immune responses might finally be able to explain why some people risk developing life-threatening COVID-19 complications. The COVID Human Genetic Effort detailed a pair of breakthrough findings about interferon issues that might put lives at risk during the course of COVID-19. The scientists found that some people have autoantibodies to interferon, while others may suffer from previously undiagnosed genetic conditions that impact interferon functionality. Whether it’s the novel coronavirus or a different infectious disease that can lead to life-threatening complications, vaccines are only a part of the solution. The biggest news of the week was the incredible announcement from Pfizer and BioNTech that says their drug was found to...

The compound UMB18 (multi-color) binds to the 3D structure of SKI protein complex shown in silver. Credit: University of Maryland School of Medicine Research Could Accelerate Efforts to Develop New Anti-Viral Drugs to Fight Flu, Ebola, and Novel Coronaviruses like COVID-19. Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. The compounds disrupt the functioning of a protein complex inside human cells that the researchers discovered is critical for the replication and survival of coronaviruses. This finding could lead to the development of new broad-spectrum antiviral drugs that target viruses such as influenza, Ebola, and coronaviruse...

The compound UMB18 (multi-color) binds to the 3D structure of SKI protein complex shown in silver. Credit: University of Maryland School of Medicine Research Could Accelerate Efforts to Develop New Anti-Viral Drugs to Fight Flu, Ebola, and Novel Coronaviruses like COVID-19. Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. The compounds disrupt the functioning of a protein complex inside human cells that the researchers discovered is critical for the replication and survival of coronaviruses. This finding could lead to the development of new broad-spectrum antiviral drugs that target viruses such as influenza, Ebola, and coronaviruse...

A man wears a protective mask as he sits near the Colosseum, as the spread of the coronavirus disease (COVID-19) continues, in Rome, Italy November 12, 2020. Guglielmo Mangiapane | Reuters The new coronavirus was circulating in Italy since September 2019, a study by the National Cancer Institute (INT) of the Italian city of Milan shows, signaling that Covid-19 might have spread beyond China earlier than previously thought. The World Health Organization has said the new coronavirus and Covid-19, the respiratory disease it causes, were unknown before the outbreak was first reported in Wuhan, in central China, in December. Italy's first Covid-19 patient was detected on Feb. 21 in a little town near Milan, in the northern region of Lombardy. But the Italian re...

The compound UMB18 (multi-color) binds to the 3D structure of SKI protein complex shown in silver. Credit: University of Maryland School of Medicine Research Could Accelerate Efforts to Develop New Anti-Viral Drugs to Fight Flu, Ebola, and Novel Coronaviruses like COVID-19. Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. The compounds disrupt the functioning of a protein complex inside human cells that the researchers discovered is critical for the replication and survival of coronaviruses. This finding could lead to the development of new broad-spectrum antiviral drugs that target viruses such as influenza, Ebola, and coronaviruse...